Pages that link to "Q30423572"
Jump to navigation
Jump to search
The following pages link to Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies (Q30423572):
Displaying 14 items.
- Impact of Human Leukocyte Antigen Loci and Haplotypes on Intestinal Acute Graft-versus-host Disease after Human Leukocyte Antigen-matched Sibling Peripheral Blood Stem Cell Transplantation (Q33755576) (← links)
- High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients. (Q33950015) (← links)
- Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failure (Q36083484) (← links)
- Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvest (Q37377933) (← links)
- The Relationship between STR-PCR Chimerism Analysis and Chronic GvHD Following Hematopoietic Stem Cell Transplantation (Q37682117) (← links)
- The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach (Q38040708) (← links)
- BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation (Q38922475) (← links)
- Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature (Q39090537) (← links)
- Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients. (Q42211287) (← links)
- Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 cases (Q43965339) (← links)
- Chronic GVHD is associated with lower relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors (Q44884259) (← links)
- GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT. (Q48261069) (← links)
- HLA antigenic and haplotype frequencies estimated in hematopoietic progenitor cell donors from Argentina (Q86047180) (← links)
- Donor characteristics and hematopoietic stem cell transplantation outcome: experience of a single center in Southern Brazil (Q90602329) (← links)